Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

U. Strathclyde spin-off MGB Biopharma gets £2mm in seed money; adds £800k

Executive Summary

Infectious disease-focused MGB Biopharma Ltd. has spun out of the University of Strathclyde and concurrently raised £2mm ($3.1mm) from angels including Archangel Informal Investments (lead), Tri Capital, Barwell PLC, and the Scottish Enterprise's Scottish Co-Investment Fund.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Spin-Off
    • Venture Financing

Related Companies